Testing a New Insulin Injection in Healthy Volunteers
Part of Hormones & metabolism clinical trials.
This study compares how a new insulin aspart injection (a fast-acting insulin) works in the body versus a reference version. Researchers will give a single injection to healthy volunteers and measure how the insulin moves through the bloodstream and affects blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy male between 18 and 55 years old
- Your weight and height must be in a healthy range (BMI between 19.0 and 28.0)
- Your blood pressure, heart rate, and blood sugar must be normal
- You cannot be allergic to insulin or have a history of diabetes or family history of diabetes
- You must not take certain medications (especially those affecting liver function or blood sugar) for at least 2–4 weeks before the study
- You cannot have had surgery in the past 3 months or have any conditions affecting how your body processes drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable medication for weight management in people with overweight or obesity. It investigates how the drug interacts with other medications and checks its safety. Participation requires a 6-month commitment with regular study visits.
This trial compares two once-daily insulin injections to see which works better and is safer for people with type 2 diabetes. Both are new types of insulin designed to help control blood sugar with fewer side effects.
This study tests if a new insulin injection made with different manufacturing methods works the same in the body. Healthy men aged 18-50 can join to help check if the new versions are as good as the original.
This early-stage study tests a new injectable medication (UBT38006) in healthy adult men to understand how safe it is and how the body processes it. Researchers want to make sure the injection doesn't cause serious side effects and works as expected.
This trial tests an experimental insulin (GZR101-80) to see if it helps control blood sugar in people with type 2 diabetes. You may join if you’ve had type 2 diabetes for at least 6 months and are between 18 and 75 years old.
This early-stage study tests whether a new oral (swallowed) form of insulin called SCD0503 works as well as regular injected insulin in men with type 1 diabetes. Researchers will also check how food affects how your body absorbs the oral insulin.
Hear when a new Pharmacokinetics and Pharmacodynamics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.